| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.43B | 17.37B | 16.98B | 14.55B | 10.26B | 12.17B |
| Gross Profit | 11.10B | 11.28B | 10.98B | 9.18B | 6.14B | 7.05B |
| EBITDA | 288.00M | 615.00M | 799.00M | -330.00M | -424.00M | -1.66B |
| Net Income | -329.00M | -19.00M | 216.00M | -1.33B | 543.00M | -5.61B |
Balance Sheet | ||||||
| Total Assets | 6.94B | 6.37B | 7.31B | 7.30B | 9.38B | 10.40B |
| Cash, Cash Equivalents and Short-Term Investments | 935.00M | 927.00M | 1.78B | 1.65B | 1.37B | 575.00M |
| Total Debt | 2.68B | 2.58B | 2.90B | 3.22B | 3.74B | 9.03B |
| Total Liabilities | 5.40B | 5.20B | 6.00B | 6.32B | 6.88B | 14.88B |
| Stockholders Equity | 1.53B | 1.16B | 1.31B | 980.00M | 2.50B | -4.48B |
Cash Flow | ||||||
| Free Cash Flow | -593.00M | -362.00M | 312.00M | 688.00M | -837.00M | -2.95B |
| Operating Cash Flow | -93.00M | 122.00M | 572.00M | 856.00M | -649.00M | -2.70B |
| Investing Cash Flow | -512.00M | -537.00M | -220.00M | 121.00M | 324.00M | 110.00M |
| Financing Cash Flow | 308.00M | -441.00M | -219.00M | -700.00M | 1.12B | 1.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥4.51B | 11.94 | ― | 0.95% | 10.67% | 36.51% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
51 Neutral | ¥4.80B | -9.62 | ― | ― | 5.28% | ― | |
47 Neutral | ¥8.15B | 2.65 | ― | ― | -2.85% | -25.67% | |
47 Neutral | ¥5.62B | 18.17 | ― | 0.32% | 6.22% | ― | |
42 Neutral | ¥5.06B | -9.69 | ― | ― | 0.64% | -156.28% | |
41 Neutral | ¥6.32B | -7.61 | ― | 0.33% | 6.62% | -2430.28% |